Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hims & Hers Health, Inc. - SIC # 7372 - PREPACKAGED SOFTWARE
Ticker
Exchange
SIC #
Website
Latest Ticker
HIMS
New York
7372
www.hims.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hims & Hers Health, Inc.
Hims & Hers Expands Integrated Health Access via Platform Expansion
- May 29th, 2026 9:17 am
Hims And Hers Canadian GLP 1 Push Tests Broader Wellness Subscription Thesis
- May 29th, 2026 1:06 am
HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform
- May 28th, 2026 9:59 pm
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
- May 28th, 2026 10:00 am
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
- May 28th, 2026 7:15 am
Hims & Hers Stock Spikes -- Insider Sends Strong Signal With $1 Million Buy
- May 27th, 2026 12:23 pm
Hims & Hers Gains 5% on Insider Buying
- May 27th, 2026 12:19 pm
HIMS vs. TEM: Which AI Healthcare Stock Offers Better Upside Now?
- May 27th, 2026 9:32 am
Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot
- May 27th, 2026 9:32 am
HIMS Stock Heads For Weekly Loss — But Ex-Netflix CFO Is Buying The Dip Despite BofA’s GLP-1 Warning
- May 26th, 2026 10:43 pm
Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA
- May 26th, 2026 12:54 pm
Live Longer and Better. Does ’Biohacking’ Really Work?
- May 26th, 2026 7:24 am
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock
- May 26th, 2026 7:00 am
How The Hims & Hers Health (HIMS) Story Is Shifting With GLP‑1 Hopes And Margin Questions
- May 24th, 2026 2:09 am
Hims & Hers Deepens Personalized Care Through Platform Expansion
- May 22nd, 2026 8:29 am
HIMS Stock Extends 3-Day Rally: Hims & Hers Targets GLP-1 Gold Rush In Canada After Novo Nordisk Patent Expiry
- May 22nd, 2026 12:24 am
The Silver Lining of Last Week's Hims & Hers Earnings Miss
- May 21st, 2026 9:40 am
Canadians can now get digital prescriptions for 'generic Ozempic'
- May 21st, 2026 8:54 am
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
- May 21st, 2026 7:00 am
Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
- May 21st, 2026 7:00 am
Scroll